# Sources — Rabindranath Tagore

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. NobelPrize.org. “Rabindranath Tagore: Biographical,” from *Nobel Lectures, Literature 1901–1967* (1969). Supports that he “was the youngest son of Debendranath Tagore, a leader of the Brahmo Samaj”, that “he also started an experimental school at Shantiniketan”, and that he “died on August 7, 1941.” The Nobel Foundation's copyright has expired. https://www.nobelprize.org/prizes/literature/1913/tagore/biographical/
2. NobelPrize.org. “The Nobel Prize in Literature 1913: Summary.” The prize citation: “because of his profoundly sensitive, fresh and beautiful verse, by which, with consummate skill, he has made his poetic thought, expressed in his own English words, a part of the literature of the West.” https://www.nobelprize.org/prizes/literature/1913/summary/
3. Wikipedia. “Rabindranath Tagore.” Supports his birth “on 7 May 1861 in the Jorasanko mansion in Calcutta”; that “the name Tagore is the anglicised transliteration of Thakur”; the sobriquets “Gurudeb, Kobiguru, and Bishwokobi”; the 1913 Nobel Prize; his founding of Visva-Bharati; that “his last five years were marked by chronic pain and two long periods of illness. These began when Tagore lost consciousness in late 1937; he remained comatose and near death for a time. This was followed in late 1940 by a similar spell, from which he never recovered”; that he dictated a poem “on 30 July 1941, a day before a scheduled operation”; and that “a period of prolonged agony ended with Tagore's death on 7 August 1941, aged 80”, at the Jorasanko house. https://en.wikipedia.org/wiki/Rabindranath_Tagore
4. Visva-Bharati. “History.” Supports that “Rabindranath's school Brahmacharyasrama … started functioning formally from December 22, 1901 with no more than five students” and that an unconventional university developed around it. https://visvabharati.ac.in/History.html
5. Maji S. Review of *The Last Days of Rabindranath Tagore in Memoirs*, translated and edited by Somdatta Mandal (2021). *Gitanjali and Beyond* 9 (Scottish Centre of Tagore Studies), 2023. The memoirs are by five women who nursed him. Supports that Maitreyi Devi accompanied “the unconscious Tagore from Kalimpong to Kolkata in September, 1940”; that “during the last two years of his life, illness confined him to four walls of the domestic fold”, with “swollen feet, numbness of fingers and frequent rise in body temperature”; that “he confessed to his associates that he was more afraid of undergoing complicated medical treatments than facing death” and “sought cure in various streams of medical science—allopathy, homeopathy and ayurvedic”; that “Dr. Bidhan Chandra Roy and Dr. Nilratan Sarkar supervised his medical treatment”; that “he was very anxious about the surgery” and asked if it would hurt; that before “the surgery, which was done on 30th July, 1941” he asked for a prayer-poem asking not for protection from danger but not to be fearful in it; the “urgent surgery at home in Jorashanko” and the “post-operative complications”; and his daughter Renuka's tuberculosis and the untimely deaths of his wife and three children. https://gitanjaliandbeyond.co.uk/wp-content/uploads/2023/10/55.-GB-9_Shyamasri-Maji.pdf
6. Mukherjee A. “Rare exhibition gives insight into the last days of Bard of Bengal, Tagore.” *Asia Times*, 21 August 2016. On an exhibition by Visva-Bharati with a prostate cancer foundation: a urologist said “it is clear he was suffering from an enlarged prostrate that was stopping his urine flow”, that “the operation was performed and it was successful. But sadly he developed septicemia and never recovered from it”; that “Tagore complained of discomfort when he was in his home in Kalimpong” and was brought back to Jorasanko; that “he refused conventional treatment, sought herbal cure and moved to Shantiniketan”; and that an operating theatre was set up for the surgery at Jorasanko. https://asiatimes.com/2016/08/rare-exhibition-gives-insight-into-the-last-days-of-bard-of-bengal-tagore/
7. Dinda A. “India pays homage to Tagore on his 75th death anniversary.” *Gulf News*, updated 15 September 2018. On a reconstruction by Rabindra Bharati University: “Tagore first fell seriously ill on September 15, 1940, when he complained of severe pain in his lower abdomen, while visiting Kalimpong”; “the doctors diagnosed him with a severe urinary tract infection”; “Tagore, who practised ayurvedic medicine, refused to undergo surgery in spite of repeated insistence from a medical team”; he was “finally operated on in Kolkata, where a balcony outside his room was transformed into an operation theatre”; “although the doctors could not operate on his inflated prostrate, they conducted a bypass surgery to remove accumulated urine and relive pain”; the vice-chancellor said “most are unaware that he was suffering from cancer in his prostate glands”; and “present day doctors believe after the surgery, the infection may have led to septicaemia.” https://gulfnews.com/world/asia/india/india-pays-homage-to-tagore-on-his-75th-death-anniversary-1.1875109
8. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. Lerner LB, et al. *Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline.* Part I, Initial Work-up and Medical Management, *J Urol* 2021;206(4):806–817 (PMID 34384237), and Part II, Surgical Evaluation and Treatment, *J Urol* 2021;206(4):818–826 (PMID 34384236). The abstracts were read; the full statements (PSA when it would change management, post-void residual, alpha-blockers before a trial without catheter, 5-alpha-reductase inhibitors for enlarged prostates, surgery for refractory retention, and procedure choice by prostate size) are as summarized in the CMID monograph below and in the guideline's published algorithm. https://pubmed.ncbi.nlm.nih.gov/34384237/
2. Sandhu JS, et al. *Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.* *J Urol* 2024;211(1):11–19. PMID 37706750. The abstract: changes to statements on combination therapy, photoselective vaporization, water vapor thermal therapy, laser enucleation, and prostatic artery embolization, and a new statement on temporary implanted prostatic devices. The AUA web page for the guideline is now titled “(2026)”; its text is behind a login and was not read. https://pubmed.ncbi.nlm.nih.gov/37706750/
3. Stoffel JT, et al. *AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.* *J Urol* 2017;198(1):153–160. PMID 28163030. The abstract: chronic retention as a post-void residual over 300 mL on two occasions for six months; high risk with hydronephrosis, stage 3 chronic kidney disease, or recurrent culture-proven infection or urosepsis; outcomes include a successful trial of voiding without catheterization. No newer joint AUA/SUFU guideline on urinary retention was found. https://pubmed.ncbi.nlm.nih.gov/28163030/
4. Hooton TM, et al. *Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.* *Clin Infect Dis* 2010;50(5):625–663. PMID 20175247. Catheter replacement before culture when it has been in place more than two weeks; 7 days of treatment with a prompt response; no treatment of asymptomatic bacteriuria. https://pubmed.ncbi.nlm.nih.gov/20175247/
5. American Geriatrics Society. *2023 Updated AGS Beers Criteria.* *J Am Geriatr Soc* 2023;71(7):2052–2081. PMID 37139824. Used for avoiding anticholinergic and sedating drugs, avoiding nonselective peripheral alpha-1 blockers, and caution with fluoroquinolones. https://pubmed.ncbi.nlm.nih.gov/37139824/
6. U.S. Preventive Services Task Force. *Prostate Cancer: Screening* (2018). Against PSA screening at 70 and older. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
7. Saper RB, et al. “Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet.” *JAMA* 2008;300(8):915–923. PMID 18728265. Cited for advice on buying tested products, not as a judgment on ayurveda. https://pubmed.ncbi.nlm.nih.gov/18728265/
8. CMID: Clinical Monitoring Intelligence Database, Benign prostatic hyperplasia monograph (Aether Forge, 2026): IPSS at baseline and every follow-up; post-void residual with retention and before procedures; urinalysis at baseline and with infection; PSA when it would change management, a new baseline about six months after a 5-alpha-reductase inhibitor, doubled for interpretation; creatinine with retention or obstruction; response visits 4 to 12 weeks after an alpha-blocker and 3 to 6 months after a 5-alpha-reductase inhibitor; post-procedure follow-up at about 1, 3, 6, and 12 months. https://patrickrutledge.github.io/topthirty/
9. Annual wellness visit: CMS Medicare Wellness Visits, the Medicare Preventive Services reference (Aether Forge, 2026), the USPSTF A and B recommendations, Colorectal Cancer (2021), Statin Use (2022), and Falls Prevention (2024), and the CDC Adult Immunization Schedule (the CDC page returned HTTP 403 to automated requests and was not read).

## Editorial resolutions

- **Index age and dates.** The episode presents him at 79, before the operation of July 1941, as the assignment asked. The synthetic date of birth is May 7, 1946, so the whole-year shift is 85 years and 2026 maps to 1941. The index visit is February 17, 2026 (true frame February 17, 1941, after the documented Kalimpong illness of September 1940). The visits are March 3 (consultation), March 17 (sick visit), March 31, April 28, June 9 (annual wellness visit), and July 14, 2026 (true frame March 3, 17, and 31, April 28, June 9, and July 14, 1941). All precede the documented operation on July 30, 1941, and his death on August 7, 1941. He turns 80 on May 7, so the wellness visit is at 80. The visit spacing follows the AUA and CMID response visits: two weeks after drainage, a trial without catheter at six weeks, a decision visit four weeks later, and a second trial after about four months of finasteride. Past medical history includes only the late-1937 loss of consciousness and the September 1940 illness at Kalimpong; the operation, its complications, and his death stay in the claims and timeline and are omitted from intake documents.
- **Presenting problem.** The episode begins before the diagnosis. Urinary retention of unknown cause (R33.9) is the intake problem, resolved on March 3, 2026, when benign prostatic hyperplasia with lower urinary tract symptoms (N40.1) and chronic urinary retention (R33.8) are recorded. The catheter-associated infection (T83.511A) is recorded at the sick visit and resolved at the March 31 visit; mild frailty (R54) is recorded on March 31. Care-plan steps decided later carry `recorded_date`: finasteride and the trial plan (March 3), the surgical counseling (March 31), and his decision (April 28).
- **Diagnostic and historical conflict.** The 1937 and 1940 illnesses, the severe urinary infection at Kalimpong, his reliance on allopathic, homeopathic, and ayurvedic treatment, his reported refusal of surgery and his fear of complicated treatment, his anxiety before the operation, the operation at Jorasanko, and his death are **D** (some probable, from news reports of university reconstructions). The enlarged prostate stopping his urine flow is a retrospective medical reading (**R**, probable). The nature of the operation conflicts: a bypass to drain urine without operating on the prostate (Gulf News, from Rabindra Bharati University's reconstruction) or an operation that “was performed and it was successful” (Asia Times, from a urologist) (**R**, disputed). Septicaemia after the operation as the cause of death is **R**, possible. Prostate cancer, stated by a vice-chancellor in 2018 and not by the urologist, is **R**, disputed, and is not adopted: the modern episode makes no cancer diagnosis, its PSA results are within the age-specific range with a low PSA density, and no MRI or biopsy is done, in keeping with his stated wishes. The operation date conflicts slightly: the memoir review and the news reports give 30 July 1941, while Wikipedia says he dictated a poem on 30 July “a day before a scheduled operation”; 30 July is preferred.
- **Not verified.** Erysipelas or any other diagnosis for the 1937 illness was not found in a source I could read and is not used. Krishna Dutta and Andrew Robinson's biography could not be read or found quoted on these points by a reliable source and is not cited. The BJU International blog post on his last days (by the urologist quoted in Asia Times) returned HTTP 404. The excerpt from Swati Ganguly's history of Visva-Bharati could not be fetched. No peer-reviewed medical-history article on his final illness was found in PubMed. The sources name the operating surgeon inconsistently; no surgeon is named in this record.
- **His values and traditional medicine.** His documented reluctance about surgery and his trust in ayurvedic treatment are recorded with respect, as documented, and the modern episode honors them: his traditional physician's herbal preparation is continued after a pharmacist's review, with advice to buy from a tested supplier (JAMA 2008), and a blood lead level is offered and declined; no product or practitioner is named, and no judgment on ayurveda is made. His decision to defer surgery after a failed trial is recorded as an informed choice with clear criteria to reconsider. His words in the modern episode (“patient, but tired of my own body”, his fear of being “put to sleep and cut”) are synthetic statements of the modern patient, not quotations from his writings; they echo, and are linked to, the documented report that he was more afraid of complicated treatment than of death. The modern episode deliberately avoids an operation and ends with a successful second trial without catheter, so it does not re-enact or comment on his real operation.
- **Real people.** His father appears only in the documented birth claim, and his daughter Renuka only in the family history (tuberculosis; cause of death not recorded in the cited source). Bidhan Chandra Roy, Nilratan Sarkar, and the women who nursed him appear only in documented claims. In the modern episode his family and helpers are unnamed; one unnamed helper notices that he was slow to answer in the night, and no relative or helper is given a decision or a health fact. His health care agent is not named.
- **Name and aliases.** “Tagore” is the anglicised form of the family name Thakur. The display name “Rabindranath Tagore” splits normally into a given name and a family name, so `name_parts` is not needed. The aliases “Rabindranath Thakur” and “Gurudev” appear in no other record. Wikipedia transliterates the sobriquet as “Gurudeb”; “Gurudev” is the common English spelling and the title of a memoir by one of his nurses.
- **Sick visit.** The sick visit (March 17, 2026; true frame March 17, 1941) is a febrile catheter-associated urinary tract infection without sepsis, four weeks into catheter drainage, treated at home with ceftriaxone and cefpodoxime for 7 days after a catheter change and cultures. It was chosen because it follows from the catheter and teaches catheter-associated infection management, delirium screening (4AT 0), and Beers-guided antibiotic choice (no fluoroquinolone). It echoes the documented urinary infection of September 1940 and the reported post-operative septicaemia, which are linked as claims, but it asserts neither.
- **Wellness visit.** At 80 the preventive visit is `annual_wellness_subsequent` (his previous wellness visit was with a former physician). It adds RSV, PCV20, and recombinant zoster vaccines, a falls referral to physiotherapy, and advance care planning with a health care agent named but not recorded by name. Prostate cancer screening is not indicated at 80; PSA is followed only as part of finasteride treatment.
- **Focused visits.** The four chronic-care follow-ups (two weeks, six weeks, ten weeks, and five months) are documented as focused visits on the CMID benign prostatic hyperplasia monograph, the AUA guideline (2021, amended 2023), the AUA chronic retention white paper, IDSA 2009, and the AGS Beers Criteria 2023: the IPSS (not scored while catheterized; 26 at intake and 13 after the second trial), post-void residual (640, 420, and 150 mL), creatinine and electrolytes, the ultrasound, PSA (4.9 ng/mL at baseline; 2.6 ng/mL after four and a half months of finasteride, doubled to 5.2), digital rectal examination, catheter care, tamsulosin and finasteride effects, culture results, the geriatric assessment (Clinical Frailty Scale 5, Timed Up and Go 15 seconds, Mini-Cog 4), the medication and herbal review, and the surgical decision. One protocol deviation is recorded as `deferred`, with its outcome and corrective action, and no result was invented: orthostatic blood pressure was not measured two to four weeks after starting tamsulosin and was first measured at six weeks, with no orthostatic hypotension and no falls. The Clinical Frailty Scale, Timed Up and Go, 4AT, and culture results are recorded in the note text; the IPSS uses the LOINC AUA symptom index score (80891-5) and its quality-of-life item (81090-3), because no separate IPSS total-score code was found.
- **Consultation.** The urology referral and consultation (Helena Marsh-Okoro, MD, a fictional consultant, on the day of the two-week visit) are **S**. The consultant finds low-risk chronic retention from benign prostatic obstruction and recommends what the record then shows: finasteride (started that day), tamsulosin with a trial without catheter at about six weeks (done, and failed), the indwelling catheter with intermittent self-catheterization offered (he preferred the indwelling catheter), no MRI or biopsy, HoLEP as the preferred operation for refractory retention with prostatic artery embolization as the less invasive option (both offered after the failed trial), a geriatric assessment before any decision (done), and a long-term catheter or a second trial after three to six months of finasteride if he declined a procedure (he chose the second trial, which succeeded).
- **Primary clinician.** Arvind Sengupta, MD, is cast as a general internist with geriatric training.
- Tagore died in 1941, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required. Claims about his illnesses, operation, and death are marked sensitive.
